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INTRODUCTION
Diabetes mellitus is a well-recognized risk factor for
the development of atherosclerotic coronary artery dis-
ease. The prevalence of diabetes in the general popula-
tion ranges around 5% worldwide, increasing up to 30%
in patients referred to cardiac surgery for myocardial
revascularization (1, 2). Previously reported prospective
randomized trials (such as the BARI or the ARTS) de-
picted the superior outcome of coronary surgery when
compared to percutaneous interventions in diabetic pa-
tients (3, 4).
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ABSTRACT: Objectives: Diabetes negatively affects the outcome of patients undergoing percu-
taneous transluminal coronary angioplasty (PTCA) or coronary surgery. However, data are lack-
ing with respect to the impact of arterial revascularization in the diabetic population.
Methods: Between 1999 and 2003, 100 of 491 diabetics underwent coronary artery bypass graft
surgery (CABG) with total arterial grafting (Group 1, G1); these patients were compared with 100
diabetics undergoing conventional CABG with saphenous veins (Group 2, G2), who were
matched for Euroscore and other risk factors such as age, obesity, hypertension, left ventricular
ejection fraction (LVEF), previous myocardial infarction and chronic obstructive pulmonary dis-
ease (COPD).
Results: Both groups had a similar number of diseased coronary vessels (G1=2.6 vs G2= 2.7)
and received a similar degree of myocardial revascularization (grafted vessels: G1=2.2 vs
G2=2.4). Early outcome was comparable between the groups in terms of ventilatory support
(G1=10.8±6 vs G2=10.4±5 hours), intensive care unit (ICU) stay (G1=24±12 vs G2=25±14 hours)
and major post-operative complications such as atrial fibrillation (G1=26% vs G2=28%), peri-op-
erative myocardial infarction (G1=1% vs G2=2%)and prolonged ventilatory support (G1=6% vs
G2=5%). Hospital mortality was 2% in G1 and 3% in G2. Angiography was performed at a mean
follow-up of 34 months in 65.9% and 71.1% of hospital survivors of G1 and G2 respectively: pa-
tients of G1 showed a significantly higher patency rate (G1=96% vs G2=83.6%, p=0.02). Addi-
tionally, patients of G1 showed a significantly lower incidence of recurrent myocardial ischemia
(G1=7 pts. vs G2=18 pts., p=0.03), late myocardial infarction (G1=2 pts. vs G2=10 pts., p=0.03)
and need for coronary reintervention (G1=1 pt. vs G2=12 pts, p=0.004).
Conclusions: Total arterial grafting in diabetic patients significantly improved the benefits of
coronary surgery providing at mid term a higher graft patency rate with a lower incidence of car-
diac related events. (Heart International 2006; 3-4: 136-40)
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Despite coronary artery bypass surgery being superi-
or to angioplasty, among those patients undergoing sur-
gical myocardial revascularization diabetics still hold
higher risk of morbidity and mortality than the non-dia-
betic population (5, 6). Total arterial myocardial revas-
cularization proved to be safe and effective and to give
superior results than conventional myocardial revascu-
larization (with left internal thoracic artery on the LAD
and additional saphenous vein grafts) (7, 8). Advantages
of arterial revascularization seem to be evident espe-
cially in the case of small target coronary vessels with
low run-off, which is a common scenario in diabetics.
We therefore sought to investigate whether total arte-
rial grafting with composite grafts may improve the out-
come in the diabetic subset of patients undergoing
CABG surgery.
METHODS
Study population
Between 1999 and 2003, 100 of 491 diabetics under-
went CABG with total arterial grafting (Group 1, G1);
these patients were compared with 100 diabetics un-
dergoing conventional CABG with left internal thoracic
artery (LITA) on left anterior descending (LAD) and addi-
tional saphenous vein grafts (Group 2, G2), who were
matched for Euroscore and other risk factors such as
age, obesity, hypertension, LVEF, previous myocardial
infarction and COPD. Baseline characteristics of pa-
tients in both groups are depicted in Table I.
Surgical technique
Following median sternotomy, arterial conduits (LITA
and RITA) were harvested together with the Radial
Artery (RA). Internal thoracic arteries were prepared as
skeletonized conduits, while the radial artery (RA) was
harvested with its surrounding fascia and satellite veins.
Total arterial composite grafts were realized in three dif-
ferent fashions, which have been previously described
(9). Briefly, in type 1 configuration the right internal tho-
racic artery (RITA) is anastomosed as Y or T graft to the
in situ LITA, whereas the RA is used as a free graft for
the right coronary system. In type 2 configuration a sim-
ple Y/T graft created with the RA anastomosed on the in
situ LITA; finally, type 3 configuration was created anas-
tomosing both the RITA and the RA on the in situ LITA, in
a double Y/T graft fashion. All Y/T grafts anastomoses
were performed with a 8/0 polypropylene running suture. 
Whenever patients underwent cardiopulmonary by-
pass, standard extracorporeal circulation was institut-
ed, under mild hypothermia with a mean arterial blood
pressure of 50 mmHg. 
In the case patients were planned to undergo my-
ocardial revascularization off-pump, once two or three
pericardial Lima stitches were placed for exposure of
lateral and posterior vessels, target coronary vessel sta-
bilization was achieved with the Guidant Axius Vacuum
Stabilizer System (Guidant Corporation – Cardiac
Surgery, Santa Clara, CA, USA). Whenever required, the
operating table was maintained in Trendelemburg posi-
tion and rotated to the left or right side according to the
different target vessel location. Additionally, the vacu-
um-assisted Xpose system (Guidant Corporation – Car-
diac Surgery, Santa Clara, CA, USA) was used in some
cases of patients undergoing revascularization of the
postero-lateral vessels.
Distal anastomoses were performed end-to-side or
side-to-side (diamond-shaped for sequential anasto-
moses) with a 8/0 polypropylene running suture. We
performed proximal anastomoses under aortic side
clamping with a 6/0 (for saphenous vein grafts) or a 7/0
(for arterial conduits) polypropylene running suture, dur-
ing rewarming. In patients receiving RA grafts, Diltiazem
was continued orally for at 6 months postoperatively. 
TABLE I - PRE-OPERATIVE CHARACTERISTICS OF DIABETIC
PATIENTS ENROLLED IN THE STUDY 
Group 1 Group 2 p
Age (yrs.) 68±4 69±5 0.43
Gender (Male/Female)  59/41 57/43 0.76
Diabetes mellitus
Type 1 12 % 14 % 0.59
Type 2 88 % 86 % 0.82
Smoking hystory 12 %  14 % 0.59
Previous MI 57 %  55 % 0.78
Hypertension 85% 84 % 0.91 
Ejection Fraction <30%  10 % 12 %  0.56
COPD 27 %  25 % 0.69
Obesity 10 % 12 %  0.56
Peripheral vascular disease  26 % 29 % 0.57
Euroscore 6.3±2.5 6.1±2.8 0.46
MI= myocardial infarction; COPD= chronic obstructive pulmonary
disease CABG surgery in diabetic patients
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Statistical analysis
Continuous variables were analyzed with the Wilcox-
on test, while the Fisher’s exact test or the chi-square
test were used for discrete variables. A p value less than
0.05 was considered to be significant. SPSS software
was used for statistical analysis (SPSS 11.0, SPSS Inc.,
Chicago, Ill).
RESULTS
Perioperative data
Both groups had a similar number of diseased coro-
nary vessels (G1=2.6±0.7 vs G2= 2.7±0.5; p=0.42) and
received a similar degree of myocardial revasculariza-
tion (grafted vessels: G1=2.2±0.4 vs G2=2.4±0.5;
p=0.34). In patients of Group 1 the different composite
arterial grafts configurations were used as follows: 75%
of patients received type 2 configuration while type 1
and 3 configurations were used in 7% and 18% of pa-
tients respectively. 
Forty-two percent of patients receving total arterial
grafting underwent off-pump coronary surgery, while
5% of patients of Group 2 were operated without car-
diopulmonary bypass (p<0.001). Aortic cross clamping
time was similar in both groups while (G1: 28±7 min vs
G2: 32±9 min; p=0.33) while cardiopulmonary bypass
time was higher in G2 (G1: 55±15 min vs G2: 78±31 min;
p<0.001) reflecting the additional time required to per-
form saphenous vein grafts (SVGs) proximal anasto-
moses.
Early outcome
Early postoperative outcome was comparable be-
tween the groups in terms of ventilatory support
(G1=10.8±6 vs G2=10.4±5 hours), ICU stay (G1=24±12
vs G2=25±14 hours) and major post-operative compli-
cations as atrial fibrillation (G1=26% vs G2=28%), peri-
operative myocardial infarction (G1=1% vs G2=2%) and
prolonged ventilatory support(G1=6% vs G2=5%): a
more detailed description of early post-operative com-
plications is depicted in Table II. 
Hospital mortality was 2% in G1 and 3% in G2: caus-
es of death were sepsis (1 pt in each group), abdominal
ischemia (1 pt in each group) and multi organ failure 
(1 pt in Group 2). Prolonged mechanical ventilation sec-
ondary to respiratory failure was the primary cause
leading to sepsis and multiple organ failure.
It is worthy of note that no patient receiving total ar-
terial grafting experienced wound complications at the
site of radial artery harvesting; conversely, 9 patients in
Group 2 had leg wound complications related to saphe-
nous vein graft harvesting (p=0.002). 
Mid-term outcome
Angiography was performed at a mean follow-up of
34 months in 63 patients (65.3%) and 71 patients
(71.7%) of hospital survivors of G1 and G2 respectively:
graft patency rates were considerable higher in Group 1
when compared to Group 2 (G1=96.4 % vs G2=83.2%,
p=0.02). Occluded grafts were 5 in Group 1 (3 radial ar-
teries and 2 right ITAs) while in Group 2 there were 27
occluded saphenous vein grafts and 1 occluded left ITA. 
Additionally, patients receiving total arterial grafting
had a better mid-term outcome with respect to inci-
dence of recurrent myocardial ischemia (G1=7 pts vs
G2=18 pts, p=0.03), late myocardial infarction (G1=2
pts vs G2=10 pts, p=0.03) and need of coronary reinter-
vention (G1=1 pt vs G2=12 pts, p=0.004).
DISCUSSION
Diabetes mellitus is a widely established risk factor
for the development of atherosclerotic coronary artery
disease. In addition, atherosclerosis is more aggressive
TABLE II - MAJOR PERI-OPERATIVE MORBIDITIES 
Group 1 Group 2 p
Atrial fibrillation 26 %  28 % 0.70
Perioperative MI 1 %  2 % 0.48
Prolonged MV 6 % 5 % 0.65 
ARF 3 % 4 %  0.61
SWC 3 %  2 % 0.47
Pulmonary infections 10 % 12 %  0.56
CVAs - 1  % 0.31
Bleeding 1 % 1 % 1
MI= myocardial infarction; MV= mechanical ventilation; ARF=
acute renal failure; SWC= sternal wound complications; CVAs=
cerebrovascular accidents Muneretto et al
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in diabetics, showing a more severe narrowing of the
native coronary vessels than in patients without dia-
betes. Several reports evidenced that the prevalence of
diabetes in the population of patients referred for my-
ocardial revascularization, either surgical or interven-
tional, raise to 30% (1, 2). Previously reported prospec-
tive randomized trials (such as the BARI and the ARTS
trials) demonstrated the superior outcome of coronary
surgery when compared to percutaneous interventions
in diabetic patients (3, 4).
Despite the improved outcome following coronary
artery bypass surgery when compared to interventional
strategies, patients undergoing surgical myocardial
revascularization diabetics are at higher risk of morbid-
ity and mortality than the non diabetic population (5-6,
10). Since total arterial myocardial revascularization
proved to have a superior clinical outcome in the gener-
al population than conventional coronary surgery (with
LITA on the LAD and additional saphenous vein grafts)
(7, 8), the aim of our study was to assess the advan-
tages of total arterial myocardial revascularization in a
population of diabetic patients when compared to con-
ventional CABG. We therefore compared a group of dia-
betics receiving total arterial grafting with patients un-
dergoing conventional myocardial revascularization,
who were matched for pre-operative characteristics
such as Euroscore and other risk factors as age, obesi-
ty, hypertension, LVEF, previous myocardial infarction
and COPD (Tab. I). Total arterial myocardial revascular-
ization did not increase hospital mortality (2% in Group
1 and 3% in Group 2), which was comparable to our
previous reported experiences with the general popula-
tion undergoing coronary surgery with composite arter-
ial grafts (11). The rate of early post-operative compli-
cations was similar in both groups, in particular with re-
spect to incidence of perioperative myocardial infarc-
tion (G1=1% vs G2=2%; p=0.48), prolonged ventilatory
support (G1=6% vs G2=5%; p=0.65) and sternal wound
complications (G1=3% vs G2=2 %; p=0.47). Converse-
ly, a considerable number of patients undergoing con-
ventional grafting with saphenous veins experienced
leg wound complications related to vein harvesting
(p=0.002), while no patient receiving total arterial graft-
ing showed wound problems at the site of radial artery
harvesting. At mid-term, total arterial myocardial graft-
ing clearly demonstrated incremental benefits when
compared to conventional coronary surgery, in terms of
higher graft patency rates (Group 1=96.4 % vs Group
2=83.2%, p=0.02) and a lower incidence of late cardiac
related events as recurrent myocardial ischemia (G1=7
pts vs G2=18 pts, p=0.03), late myocardial infarction
(G1=2 pts vs G2=10 pts, p=0.03) and need of coronary
reintervention (G1=1 pt vs G2=12 pts, p=0.004).
In conclusion, diabetes affects a steadily higher num-
ber of patients undergoing coronary artery bypass
surgery and the aggressiveness and the degree of
atheromatous degeneration in those patients is more
significant with an important reduction of both coronary
artery diameter and run-off. Percutaneous interventions
proved to have less efficacy than surgical myocardial
revascularization (3, 4) in this specific subset of pa-
tients. However, it should be stressed that the patients
enrolled in prospective, randomized trials like the BARI
and the ARTS, underwent coronary surgery with the
conventional technique (LITA on LAD plus additional
saphenous vein grafts). Total arterial myocardial graft-
ing proved to be a safe and effective technique even in
the diabetic population, providing incremental benefits
and better mid-term outcome when compared to the
conventional CABG surgery. It could therefore be fore-
seen that the advantages of total arterial multivessel
grafting may hold more striking evidence of the benefits
of surgical revascularization over percutaneous inter-
ventions.
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